PE20081844A1 - DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR V1a - Google Patents

DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR V1a

Info

Publication number
PE20081844A1
PE20081844A1 PE2008000047A PE2008000047A PE20081844A1 PE 20081844 A1 PE20081844 A1 PE 20081844A1 PE 2008000047 A PE2008000047 A PE 2008000047A PE 2008000047 A PE2008000047 A PE 2008000047A PE 20081844 A1 PE20081844 A1 PE 20081844A1
Authority
PE
Peru
Prior art keywords
indol
alkyl
carbonyl
azaspiropiperidine
derivatives
Prior art date
Application number
PE2008000047A
Other languages
English (en)
Inventor
Caterina Bissantz
Chirstophe Grundschober
Raffaello Masciadri
Hasane Ratni
Mark Rogers-Evans
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20081844A1 publication Critical patent/PE20081844A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Abstract

SE REFIERE A DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA DE FORMULA (I), EN DONDE U ES O Y V ES CH2, o U ES O Y V ES C=O, o U ES CH2 Y V ES O, o U ES CH2 y V ES O; o U-V ES -CH=CH-, ENTRE OTROS; UNA O DOS VARIABLES W, X, Y y Z SON NITROGENO, SIENDO EL RESTO DE LAS VARIABLES CR8; R1 ES H, ALQUILO(C1-C12), HALOALQUILO(C2-C6), -(CRiRii)m-Ra; ENTRE OTROS; R2 ES H, ALQUILO(C1-C6), -C(O)Rn, NRjRK; R3, R4, R5 Y R6 SON INDEPENDIENTEMENTE H, HALO, ALQUILO(C1-C6), HALOALQUILO(C1-C6), ENTRE OTROS; O R1 Y R6 JUNTO CON EL INDOL AL QUE ESTAN UNIDOS FORMAN UN HETEROCICLO DE 6 MIEMBROS OPCIONALMENTE SUSTITUIDOS; R7 ES H O ALQUILO(C1-C6). SON SELECCIONADOS 1'-[(6-CLORO-1H-INDOL-3-IL)CARBONIL]-7H-SPIRO[FURO-[3,4-b]PIRIDINA-5,4'-PIPERIDINA], (2S)-2-{[6-CLORO-3-(1'H,7H-SPIRO[FURO-[3,4-b]PIRIDINA-5,4'-PIPERIDIN]-1'-ILCARBONIL)-1H-INDOL-1-IL-]METIL}-PIRROLIDINA-1-CARBOXILATO DE TREC-BUTILO. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE V1a, POR LO QUE SON UTILES EN EL TRATAMIENTO DE DISMENORREA, HIPERTENSION, FALLO CARDIACO CRONICA, ANSIEDAD, TRASTORNOS DEPRESIVOS
PE2008000047A 2006-12-29 2008-01-02 DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR V1a PE20081844A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06127334 2006-12-29

Publications (1)

Publication Number Publication Date
PE20081844A1 true PE20081844A1 (es) 2009-01-26

Family

ID=39201403

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000047A PE20081844A1 (es) 2006-12-29 2008-01-02 DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR V1a

Country Status (22)

Country Link
US (3) US8039624B2 (es)
EP (1) EP2125827B1 (es)
JP (1) JP2010514727A (es)
KR (1) KR101129861B1 (es)
CN (1) CN101589046B (es)
AR (1) AR064547A1 (es)
AT (1) ATE486877T1 (es)
AU (1) AU2007341379B2 (es)
BR (1) BRPI0720827A2 (es)
CA (1) CA2674154A1 (es)
CL (1) CL2007003832A1 (es)
DE (1) DE602007010359D1 (es)
DK (1) DK2125827T3 (es)
ES (1) ES2351949T3 (es)
MX (1) MX2009006921A (es)
NO (1) NO20092342L (es)
PE (1) PE20081844A1 (es)
PL (1) PL2125827T3 (es)
PT (1) PT2125827E (es)
RU (1) RU2009124419A (es)
TW (1) TW200835483A (es)
WO (1) WO2008080844A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008068185A1 (en) * 2006-12-07 2008-06-12 F. Hoffmann-La Roche Ag Spiro-piperidine derivatives as via receptor antagonists
MX2009006454A (es) * 2006-12-22 2009-06-26 Hoffmann La Roche Derivados de espiro-piperidina.
AR077280A1 (es) 2009-06-29 2011-08-17 Incyte Corp Pirimidinonas como inhibidores de pi3k, y composiciones farmaceuticas que los comprenden
AR078948A1 (es) * 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
EP2558463A1 (en) 2010-04-14 2013-02-20 Incyte Corporation Fused derivatives as i3 inhibitors
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
TW201249844A (en) 2010-12-20 2012-12-16 Incyte Corp N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
ES2464598T3 (es) 2011-07-22 2014-06-03 Université Joseph Fourier Nuevos derivados bis-indólicos, procedimiento para su preparación, y sus utilizaciones como fármaco
SI2751109T1 (sl) 2011-09-02 2017-03-31 Incyte Holdings Corporation Heterociklilamini kot inhibitorji pi3k
CN102568615B (zh) * 2011-12-13 2013-05-22 华中科技大学 一种小型精密调平装置
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
CN117800973A (zh) 2015-02-27 2024-04-02 因赛特控股公司 Pi3k抑制剂的盐及其制备方法
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
UY38934A (es) 2019-10-29 2021-05-31 Biogen Ma Inc Inhibidores de o-glucoproteína-2-acetamido-2-deoxi-3-d-glucopiranosidasa espirocíclica

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761992B1 (fr) * 1997-04-09 1999-06-11 Hoechst Marion Roussel Inc Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
TWI279402B (en) * 1999-08-20 2007-04-21 Banyu Pharma Co Ltd Spiro compounds having NPY antagonistic activities and agents containing the same
GB0003397D0 (en) 2000-02-14 2000-04-05 Merck Sharp & Dohme Therapeutic agents
KR100854872B1 (ko) * 2003-12-22 2008-08-28 화이자 인코포레이티드 바소프레신 길항제로서의 트리아졸 유도체
GB0400700D0 (en) * 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
GB0504556D0 (en) * 2005-03-04 2005-04-13 Pfizer Ltd Novel pharmaceuticals

Also Published As

Publication number Publication date
DK2125827T3 (da) 2010-12-20
PL2125827T3 (pl) 2011-04-29
MX2009006921A (es) 2009-07-06
DE602007010359D1 (de) 2010-12-16
WO2008080844A9 (en) 2009-10-08
CA2674154A1 (en) 2008-07-10
ATE486877T1 (de) 2010-11-15
AR064547A1 (es) 2009-04-08
CL2007003832A1 (es) 2008-07-25
CN101589046B (zh) 2011-09-21
EP2125827B1 (en) 2010-11-03
US20080161332A1 (en) 2008-07-03
RU2009124419A (ru) 2011-02-10
US8039624B2 (en) 2011-10-18
TW200835483A (en) 2008-09-01
US20080281103A1 (en) 2008-11-13
EP2125827A1 (en) 2009-12-02
NO20092342L (no) 2009-07-02
AU2007341379B2 (en) 2012-05-24
US8044202B2 (en) 2011-10-25
PT2125827E (pt) 2010-11-22
BRPI0720827A2 (pt) 2014-03-04
ES2351949T3 (es) 2011-02-14
KR101129861B1 (ko) 2012-04-24
CN101589046A (zh) 2009-11-25
US8034937B2 (en) 2011-10-11
KR20090094172A (ko) 2009-09-03
AU2007341379A1 (en) 2008-07-10
WO2008080844A1 (en) 2008-07-10
US20080161333A1 (en) 2008-07-03
JP2010514727A (ja) 2010-05-06

Similar Documents

Publication Publication Date Title
PE20081844A1 (es) DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR V1a
AR063318A1 (es) Pirazoliltienopiridinas terapeuticas
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR049388A1 (es) Heterociclos como inhibidores de aldosterona sintasa
PE20170144A1 (es) 1h-pirrolo[2,3-c] piridin-7(6h)-onas y pirazolo[3,4-c]piridin-7(6h)-onas como inhibidores de proteinas bet
PE20120031A1 (es) Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1
PE20170003A1 (es) Compuestos heterociclicos y usos de los mismos
AR052580A1 (es) Antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias
AR086546A1 (es) Derivados de 7h-purin-8(9h)-ona como inhibidores de jak
AR074596A1 (es) Derivados de (3-oxo) piridazin-4-ilurea
AR080688A1 (es) Derivados de 2,3-dihidro-1h-inden-1-il-2,7-diazaspiro[3.5]nonano como agonistas o antagonistas inversos de grelina
EP3105225A1 (en) Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
PE20060486A1 (es) Derivados de pirrol-oxindol como moduladores del receptor de progesterona
AR062360A1 (es) Derivados heterociclicos que modulan la actividad de la estearoil-coa-desaturasa
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
AR044874A1 (es) Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica
AR035716A1 (es) Compuestos agonistas del receptor beta3-adrenergico, uso de los mismos en la fabricacion de medicamentos y composiciones farmaceuticas conteniendo los mismos
RU2010101279A (ru) 1-цианоциклопропильные производные в качестве ингибиторов катепсина к
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
AR038000A1 (es) Compuesto derivado de tien[2,3-d]pirimidin-2,4(1h,3h)-diona, composicion farmaceutica, proceso para su preparacion y su uso en la fabricacion de un medicamento
AR064831A1 (es) Derivados de espiropiperidina-glicinamida
UY29204A1 (es) Compuestos de imidazo(1,2-a)piridina, composiciones, usos y métodos relacionados
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
PE20130401A1 (es) Heteroaril-ciclohexil-tetraazabenzo[e]azulenos
PE20191349A1 (es) Inhibidores de mnk sustituidos con piperidina y metodos relacionados con los mismos

Legal Events

Date Code Title Description
FC Refusal